SYBX: Synlogic, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 12.87
Enterprise Value ($M) -4.40
Book Value ($M) 13.09
Book Value / Share 1.12
Price / Book 0.98
NCAV ($M) 13.04
NCAV / Share 1.12
Price / NCAV 0.99

Profitability (mra)
Return on Invested Capital (ROIC) 0.20
Return on Assets (ROA) 0.07
Return on Equity (ROE) 0.19

Liquidity (mrq)
Quick Ratio 3.68
Current Ratio 3.68

Balance Sheet (mrq) ($M)
Current Assets 17.92
Assets 17.97
Liabilities 4.87
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.01
Operating Income -15.78
Net Income -23.36
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -31.66
Cash from Investing 25.34
Cash from Financing 0.17

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-25 13G/A Kryzanowski John A 6.27 -16.06
11-14 13G/A Armistice Capital, Llc 4.99 -52.22
05-16 13D/A New Enterprise Associates 14, L.P. 25.00 0.00
2024-04-18 13G Radoff Bradley Louis 5.40

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2025-04-30 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1)
2025-03-06 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-13 1,690 11,402 14.82
2025-05-12 9,064 31,908 28.41
2025-05-09 11 7,016 0.16

(click for more detail)

Similar Companies
SRZN – Surrozen, Inc. SXTC – China SXT Pharmaceuticals, Inc.
SXTP – 60 Degrees Pharmaceuticals, Inc. TCRT – Alaunos Therapeutics, Inc.
TELO – Telomir Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io